Hercules Capital Inc.’s (HTGC) first-quarter 2025 net investment income of 45 cents per share missed the Zacks Consensus Estimate by a penny. The bottom line declined 10% from the year-ago quarter.  Results were adversely affected by weak performance in the interest, dividend and fee income.  However, a slight reduction in net operating expenses by 0.8% was positive.  Net investment income was $77.5 million, down 2.2% year over year.HTGC's Investment Income Down, Expenses RiseTotal investment income in the ...

Hercules Capital (HTGC) reported $119.51 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 1.7%. EPS of $0.45 for the same period compares to $0.50 a year ago.The reported revenue represents a surprise of -1.91% over the Zacks Consensus Estimate of $121.83 million. With the consensus EPS estimate being $0.46, the EPS surprise was -2.17%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...

Hercules Capital (HTGC) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.17%. A quarter ago, it was expected that this specialty finance company would post earnings of $0.49 per share when it actually produced earnings of $0.49, delivering no surprise.Over the last four quarters, th ...

Q1 2025 Total Gross Debt and Equity Commitments of $1.02 Billion Q1 2025 Total Gross Fundings of $539.1 Million Q1 2025 Total Investment Income of $119.5 Million Q1 2025 Net Investment Income "NII" of $77.5 Million, or $0.45 per Share Q1 2025 NII of $0.45 per Share provides 113% Coverage of the Base Cash Distribution Received an Investment Grade Rating Upgrade to BBB (high) from Morningstar DBRS Closed Offering of $287.5 Million of 4.750% Convertible Unsecured Notes due 2028 Exhibit 99.1 Hercules Capital Re ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _________________________________________________ FORM 10-Q _________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarterly Period Ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 814-00702 _________________________________________________ HERCULE ...

Company Performance - Hercules Capital (HTGC) closed at $16.83, unchanged from the previous session, lagging behind the S&P 500's gain of 1.81% [1] - The company has experienced a 6.55% decline in share price over the past month, while the Finance sector and S&P 500 lost 4.82% and 6.14%, respectively [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $0.46, reflecting an 8% decrease from the same quarter last year [2] - Revenue is anticipated to be $121.83 million, indicating a slight increase of 0.23% compared to the prior year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $1.95 per share, down 2.5% from the previous year, while revenue is expected to reach $518.17 million, up 4.98% [3] - Recent changes in analyst estimates suggest a shifting business landscape, with positive revisions indicating a favorable outlook for the company [3] Valuation Metrics - Hercules Capital has a Forward P/E ratio of 8.63, which is higher than the industry average of 7.97 [6] - The Financial - SBIC & Commercial Industry, part of the Finance sector, holds a Zacks Industry Rank of 183, placing it in the bottom 27% of over 250 industries [6] Zacks Rank System - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently rates Hercules Capital at 3 (Hold) [5] - The consensus EPS projection has decreased by 0.2% in the last 30 days, indicating a cautious sentiment [5]

Agreement with Hercules Capital significantly increases financial and operational strength, provides up to $500 million in capital with no dilution to shareholders, an attractive cost of capital and low operational and strategic incumbrances, and sets a new standard for the quantum of a nondilutive facility for a development-stage therapeutics company.Facility adds to the $448 million cash position disclosed in previously filed 10-K and provides funding for the next steps of the Company's growth, including ...

Group 1: Stock Performance - Hercules Capital (HTGC) closed at $19.32, with a +0.42% movement compared to the previous day, underperforming the S&P 500 which gained 1.77% [1] - The stock has decreased by 10.39% over the past month, compared to a loss of 1.46% in the Finance sector and a 5.73% loss in the S&P 500 [1] Group 2: Earnings Projections - The upcoming EPS for Hercules Capital is projected at $0.46, indicating an 8% decline from the same quarter last year [2] - Quarterly revenue is estimated at $121.83 million, reflecting a slight increase of 0.23% from the previous year [2] Group 3: Fiscal Year Estimates - For the entire fiscal year, earnings are expected to be $1.96 per share, representing a -2% change from the previous year [3] - Revenue for the fiscal year is projected at $520.16 million, indicating a +5.38% change from the prior year [3] Group 4: Analyst Estimates and Ratings - Recent adjustments to analyst estimates for Hercules Capital are being monitored, as upward revisions indicate positive sentiment regarding the company's operations [4] - The Zacks Rank system, which evaluates estimated changes, currently ranks Hercules Capital at 3 (Hold) [6] Group 5: Valuation Metrics - Hercules Capital has a Forward P/E ratio of 9.84, which is higher than the industry average Forward P/E of 8.85 [7] - The Financial - SBIC & Commercial Industry, part of the Finance sector, holds a Zacks Industry Rank of 131, placing it in the bottom 48% of over 250 industries [7]

Core Insights - Mr. Mavroudis is a professional portfolio manager with a focus on risk management and in-depth financial market analysis [1] - He has successfully navigated major crises, including the COVID-19 pandemic and the PSI [1] - Mr. Mavroudis is the CEO of FAST FINANCE Investment Services, a registered Greek company [1] Professional Background - Mr. Mavroudis holds multiple degrees, including an MSc in Financial and Banking Management, an LLM in Law, and a BSc in Economics, graduating as valedictorian [1] - He is a certified portfolio manager and holds various certifications related to financial instruments, derivatives, and securities [1] - He is also a licensed Class A accountant-tax consultant and a member of the Economic Chamber of Greece [1] Contributions and Engagement - Mr. Mavroudis writes daily articles for reputable financial media and appears as a guest commentator on television and online programs [1] - He has published three books on investments and teaches in educational seminars [1] - By writing on Seeking Alpha, he aims to engage with a community of investors and market enthusiasts, fostering mutual growth and knowledge sharing [1]

Core Viewpoint - The article discusses the reliability of brokerage recommendations, particularly focusing on Hercules Capital (HTGC), and suggests that while the average brokerage recommendation (ABR) indicates a favorable outlook, investors should be cautious and validate these recommendations with other tools like Zacks Rank [1][3][5]. Group 1: Brokerage Recommendations - Hercules Capital has an average brokerage recommendation (ABR) of 1.78, indicating a position between Strong Buy and Buy, based on recommendations from nine brokerage firms [2]. - Of the nine recommendations, five are Strong Buy and one is Buy, which account for 55.6% and 11.1% of all recommendations respectively [2]. - Despite the positive ABR, studies indicate that brokerage recommendations often do not effectively guide investors towards stocks with the highest potential for price appreciation [3][4]. Group 2: Limitations of Brokerage Recommendations - Brokerage firms often exhibit a positive bias in their ratings due to vested interests, leading to a disproportionate number of Strong Buy recommendations compared to Strong Sell [4][8]. - The interests of brokerage firms may not align with those of retail investors, providing limited insight into future stock price movements [5]. - Analysts' recommendations tend to be overly optimistic, which can mislead investors more often than they provide accurate guidance [8]. Group 3: Zacks Rank as an Alternative - Zacks Rank categorizes stocks into five groups based on earnings estimate revisions, which are more effective indicators of near-term stock price performance compared to ABR [6][9]. - The Zacks Rank is updated more frequently, reflecting changes in earnings estimates promptly, while ABR may not always be current [10]. - For Hercules Capital, the Zacks Consensus Estimate for the current year remains unchanged at $1.96, suggesting that the stock may perform in line with the broader market [11]. Group 4: Current Status of Hercules Capital - The recent change in consensus estimate and other factors have resulted in a Zacks Rank 3 (Hold) for Hercules Capital, indicating a cautious approach despite the Buy-equivalent ABR [12].